OncoMed Pharmaceuticals, Inc.  

Our Mission

OncoMed Pharmaceuticals is a clinical-stage biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.

For Cancer Patients

Clinical trials are essential to obtain the data required for regulatory approval in order to make new medicines broadly available to patients and their prescribing physicians. OncoMed is currently conducting numerous clinical trials of our therapeutic candidates. To participate in one of our ongoing clinical trials, contact the OncoMed Clinical Trial Matching Service at 866-914-7347 (USA) or oncomed@emergingmed.com.

R&D Day

April 29, 2015 in NYC OncoMed 2015 Research & Development Day

Latest Presentations

November 2015 Society for Immunotherapy of Cancer (SITC) Annual Meeting November 2015 AACR-NCI-EORTC International Conference on Molecular Targets and cancer Therapeutics